Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A distinctive ovarian cancer molecular subgroup characterized by poor prognosis and somatic focal copy number amplifications at chromosome 19.

Gynecologic oncology - 1 Feb 2014

Sung Chang Ohk, Song In-Hye, Sohn Insuk

Abstract excerpt

OBJECTIVE: High-grade serous ovarian cancer (HGS-OvCa), the most common epithelial ovarian cancer, is very complex and heterogeneous at the molecular level. The identification of intrinsic HGS-OvCa subgroups characterized by specific molecular alterations and aggressive behavior could improve patient treatment. METHODS: High-resolution copy number data for 560 HGS-OvCa patients and gene expression data obtained...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Ovarian Epithelial
Share to Chromosomes, Human, Pair 19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystadenocarcinoma, Serous

Share to Disease-Free Survival

Share to Gene Amplification

Share to Gene Dosage

Share to Neoplasms, Glandular and Epithelial

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 24321399
DOI: 10.1016/j.ygyno.2013.11.036

Genes

HGS
BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A distinctive ovarian cancer molecular subgroup characterized by poor prognosis and somatic focal copy number amplifications at chromosome 19.PMID 24321399Read ↗

Chromosome instability region analysis and identification of the driver genes of the epithelial ovarian cancer cell lines A2780 and SKOV3Semantic proximity Read ↗

Genome Wide DNA Copy Number Analysis of Serous Type Ovarian Carcinomas Identifies Genetic Markers Predictive of Clinical OutcomeSemantic proximity Read ↗

Molecular landscape and functional characterization of centrosome amplification in ovarian cancerSemantic proximity Read ↗

19q12 amplified and non-amplified subsets of high grade serous ovarian cancer with overexpression of cyclin E1 differ in their molecular drivers and clinical outcomesSemantic proximity Read ↗

Molecular landscape and functional characterization of centrosome amplification in ovarian cancerSemantic proximity Read ↗

Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancerSemantic proximity Read ↗

Functional characterization of the 19q12 amplicon in grade III breast cancersSemantic proximity Read ↗

Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian CancerSemantic proximity Read ↗

Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis.Semantic proximity Read ↗

Genome-wide-array-based comparative genomic hybridization reveals genetic homogeneity and frequent copy number increases encompassing CCNE1 in fallopian tube carcinoma.Semantic proximity Read ↗

MED29, A Subunit of the Mediator Complex, Possesses Oncogenic Characteristics in Ovarian CancerSemantic proximity Read ↗

Copy Number Analysis Identifies Novel Interactions Between Genomic Loci in Ovarian CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.